Results 211 to 220 of about 184,127 (310)

Patterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From 2001 to 2011: China PEACE‐Retrospective AMI Study [PDF]

, 2015
Jiamin Liu, Frederick A. Masoudi, John A. Spertus, Qing Wang, Karthik Murugiah, Erica S. Spatz, Jing Li, Xi Li, Joseph S. Ross, Harlan M. Krumholz, Lixin Jiang   +10 more
openalex   +1 more source

Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in Older Patients with acute Myocardial Infarction after a Successful Stent Implantation. [PDF]

Ann Geriatr Med Res
Ko G, Lee JG, Boo KY, Choi JH, Kim SY, Joo SJ, Hwang JY, Hur SH, Oh SK, Jeong MH.   +9 more
europepmc   +1 more source

Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors. [PDF]

Nat Commun, 2023
Yu Z, Huang JP, Yang J, Liu C, Yan Y, Wang L, Zhao J, Chen Y, Xiang W, Huang SX.   +9 more
europepmc   +1 more source

Geographic region variation in patient characteristics, clinical outcomes and treatment of HFrEF in the VICTORIA trial

ESC Heart Failure, EarlyView.
Central Illustration caption: This analysis of vericiguat's treatment effect revealed no inter‐geographic region heterogeneity for the primary composite endpoint (time to HF‐related hospitalization or cardiovascular (CV) death or its components) (Left Panel).
Cynthia M. Westerhout, Wendimagegn Alemayehu, Alain Cohen‐Solal, Carolyn S. P. Lam, Justin A. Ezekowitz, Stefano Corda, Ciaran J. McMullan, Christopher M. O'Connor, Paul W. Armstrong, for the VICTORIA Study Group   +9 more
wiley   +1 more source

Successful Treatment of Severe Hypertension with the Combination of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker

, 2003
Masayuki Tanemoto, Takaaki Abe, Noriyuki Obara, Michiaki Abe, Fumitoshi Satoh, Sadayoshi Ito   +5 more
openalex   +2 more sources

Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor [PDF]

, 1995
Sarah E. Telford, A. Ian Smith, Rebecca A. Lew, Rose Perich, Anna C. Madden, Roger G. Evans   +5 more
openalex   +1 more source

Angiotensin-converting enzyme inhibitors for ovarian cancer? — a new adjuvant option or a silent trap

, 2023
Katarzyna Regulska, Marcin Michalak, Tomasz Kolenda, Joanna Kozłowska-Masłoń, Kacper Guglas, Beata Stanisz   +5 more
openalex   +2 more sources

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study. [PDF]

Cardiovasc Diabetol
Zeng W, Wang T, Stürmer T, He N, Shen P, Lin H, Guan X, Xu Y.   +7 more
europepmc   +1 more source

Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study

ESC Heart Failure, EarlyView.
Using EndoWings™ and XDROP™, we developed a percutaneous minimally invasive technique for sequential circumferential alginate hydrogel injection into LV free mid‐wall. This human study assessed its safety/feasibility in HFrEF patients, with personalised biomechanical models.
Bo Wang, Shuo Wang, Chao Gao, D. Scott Lim, Rutao Wang, Xin Meng, Ying Liu, Cun‐jun Zhu, Yoshinobu Onuma, Yunbing Wang, Patrick W.J.C. Serruys, Runlin Gao, Randall J. Lee, Ling Tao   +13 more
wiley   +1 more source

Cardiovascular Events in Hypertension Trials of Angiotensin‐Converting Enzyme Inhibitors

, 2005
W.J. Elliott
openalex   +2 more sources